CROHN'S DISEASE

This early-stage study is testing the safety and tolerability of an oral herbal formula called E-B-FAHF-2 in adults with mild-to-moderate Crohn's disease. The goal is to see if this concentrated plant-based medicine can safely help maintain remission, filling a gap where few appr…

This was an early, small safety study to test injections of donor stem cells into painful, hard-to-heal fistulas in people with Crohn's disease. The goal was to see if the treatment was safe and if it could help close these fistulas and improve patients' quality of life. The tria…

This study is observing patients with moderate to severe Crohn's disease who are already being treated with the drug Entyvio (vedolizumab) in their regular doctor's care. The main goal is to collect long-term information on the drug's safety and how well it works to control the d…

This study is testing the long-term effectiveness and safety of the drug mirikizumab for people with Crohn's disease. It follows nearly 1,000 patients who completed earlier studies of the same medication. Researchers are measuring whether the drug continues to reduce intestinal i…

This large clinical trial is testing whether the medication guselkumab can help people with moderate to severe Crohn's disease. It involves over 1,400 participants and will measure if the drug reduces symptoms and improves gut healing over nearly a year. The study compares guselk…

This study is testing whether combining two existing drugs, guselkumab and golimumab, is better at controlling Crohn's disease than using either drug alone. It involves about 700 adults with moderate to severe Crohn's disease. The main goal is to see if the combination leads to f…

This study is testing whether an injectable medication called risankizumab can help control symptoms and reduce gut inflammation in adults with moderate to severe Crohn's disease. Participants will receive either the active drug or a placebo injection for up to 24 weeks, followed…

This study is testing whether two special diets can help people with active Crohn's disease or ulcerative colitis. Forty adults will follow either a partial liquid elemental diet or a specific carbohydrate diet for six weeks. Researchers will check if the diets reduce gut inflamm…

This study is collecting long-term health information from nearly 5,000 children and teenagers with Crohn's disease, ulcerative colitis, or other inflammatory bowel diseases. Researchers will follow participants for up to 20 years to understand the safety of treatments and how th…

This study is creating a large, long-term registry of patients with Crohn's disease or ulcerative colitis to learn how these conditions behave and how treatments perform in everyday clinic settings. It will follow 15,000 adults and children (age 2+) for five years, collecting inf…

This study is collecting information about how Brazilian patients with Crohn's disease or ulcerative colitis use the medication vedolizumab. Researchers are reviewing existing treatment records from about 1006 patients to understand how long they stay on treatment and what outcom…

This study is observing how a new online tool, called CDPATH™, is used in regular doctor's offices. The tool estimates an adult patient's risk of developing Crohn's disease complications within the next three years. Researchers are enrolling about 200 recently diagnosed patients …